C6orf204 anticorps (AA 451-550) (AbBy Fluor® 594)

N° du produit ABIN2810898

Détail du produit anti-C6orf204 anticorps (AbBy Fluor® 594)

Antigène: C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))

Épitope: AA 451-550

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C6orf204 est conjugé à/à la AbBy Fluor® 594

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C6orf204

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur C6orf204

Antigène: C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))

Autre désignation: C6orf204 (CEP85L Produits)

Synonymes: anticorps C6orf204, anticorps NY-BR-15, anticorps bA57K17.2, anticorps centrosomal protein 85 like, anticorps CEP85L

Sujet:

Synonyms: bA57K17.2, C6orf204, centrosomal protein 85 kDa-like, CE85L_HUMAN, Coiled-coil domain-containing protein C6orf204, NY-BR-15, RP11-57K17.2, Serologically defined breast cancer antigen NY-BR-15.

Background: Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf204 gene product has been provisionally designated C6orf204 pending further characterization.

ID gène: 387119